HIGHLIGHTS
- who: Mariana Tannoury and collaborators from the Centre de Recherche des Cordeliers, Sorbonne Universitu00e9, Universitu00e9 Paris Citu00e9, Inserm, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Paris, France have published the research: Current Status of Novel Agents for the Treatment of B Cell Malignancies: Whatu2019s Coming Next?, in the Journal: Cancers 2022, 14, 6026. of /2022/
SUMMARY
The balance between cell death and cell proliferation contributes to the maintenance of tissue homeostasis. Cell death evasion is a hallmark of human cancers (including B cell malignancies; Table 1) and might contribute to treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.